As of Jul 27
| -1.82 / -0.34%|
The 24 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 520.50, with a high estimate of 650.00 and a low estimate of 450.00. The median estimate represents a -3.62% decrease from the last price of 540.03.
The current consensus among 26 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.